What is the current valuation of the cardiovascular devices market in 2024?

The cardiovascular devices market was valued at 1420.0 $ Million in 2024. Read More

What is the projected market valuation for 2035?

The market is projected to reach 2870.0 $ Million by 2035. Read More

What is the expected CAGR for the cardiovascular devices market during 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 6.61%. Read More

Which companies are the key players in the cardiovascular devices market?

Key players include Medtronic, Abbott, Boston Scientific, Johnson & Johnson, B. Braun, Edwards Lifesciences, Terumo, Stryker, and Philips. Read More

How did the Diagnostic Devices segment perform in 2024?

The Diagnostic Devices segment was valued between 300.0 $ Million and 600.0 $ Million in 2024. Read More

What is the valuation range for the Therapeutic Devices segment?

The Therapeutic Devices segment was valued between 500.0 $ Million and 1000.0 $ Million in 2024. Read More

Which application areas are driving growth in the cardiovascular devices market?

Application areas include Coronary Artery Disease, Heart Failure, Arrhythmia, and Valvular Heart Disease. Read More

What is the expected performance of the Cardiac Stents segment?

The Cardiac Stents segment is projected to be valued between 500.0 $ Million and 1000.0 $ Million in 2024. Read More

GCC Cardiovascular Devices Market

Q: What are the main segments of the cardiovascular devices market?

The main segments include Diagnostic Devices, Monitoring Devices, Therapeutic Devices, and Surgical Devices. Read More

Q: What are the primary end users of cardiovascular devices?

Primary end users include Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Home Healthcare. Read More

GCC Cardiovascular Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical Devices), By Applications (Coronary Artery Disease, Heart Failure, Arrhythmia, Valvular Heart Disease), By End Users (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Home Healthcare) and By Technology (Implantable Pacemakers, Cardiac Stents, Ablation Devices, Heart Valve Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.61%

2024 Market Size

$ 1,420 Million

2035 Market Size

$ 2,870 Million

Medical Device ● Updated April 2026 Report ID: MRFR/MED/49942-HCR | Pages: 200 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Type (USD Million)
  1. 4.1.1 Diagnostic Devices
  2. 4.1.2 Monitoring Devices
  3. 4.1.3 Therapeutic Devices
  4. 4.1.4 Surgical Devices
2. 4.2 Construction, BY Application (USD Million)
  1. 4.2.1 Coronary Artery Disease
  2. 4.2.2 Heart Failure
  3. 4.2.3 Arrhythmia
  4. 4.2.4 Valvular Heart Disease
3. 4.3 Construction, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Cardiac Centers
  3. 4.3.3 Ambulatory Surgical Centers
  4. 4.3.4 Home Healthcare
4. 4.4 Construction, BY Technology (USD Million)
  1. 4.4.1 Implantable Pacemakers
  2. 4.4.2 Cardiac Stents
  3. 4.4.3 Ablation Devices
  4. 4.4.4 Heart Valve Devices
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 B. Braun (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Edwards Lifesciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Terumo (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Philips (NL)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY TYPE
3. 6.3 GCC MARKET ANALYSIS BY APPLICATION
4. 6.4 GCC MARKET ANALYSIS BY END USER
5. 6.5 GCC MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY END USER, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Cardiovascular Devices Market Segmentation

GCC Cardiovascular Devices Market By Type (USD Million, 2025-2035)

Diagnostic Devices
Monitoring Devices
Therapeutic Devices
Surgical Devices

GCC Cardiovascular Devices Market By Application (USD Million, 2025-2035)

Coronary Artery Disease
Heart Failure
Arrhythmia
Valvular Heart Disease

GCC Cardiovascular Devices Market By End User (USD Million, 2025-2035)

Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Home GCC Cardiovascular Devices Market

GCC Cardiovascular Devices Market By Technology (USD Million, 2025-2035)

Implantable Pacemakers
Cardiac Stents
Ablation Devices
Heart Valve Devices

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”